PE20071238A1 - Proceso para la preparacion de heterociclos hidroxi substituidos - Google Patents

Proceso para la preparacion de heterociclos hidroxi substituidos

Info

Publication number
PE20071238A1
PE20071238A1 PE2007000019A PE2007000019A PE20071238A1 PE 20071238 A1 PE20071238 A1 PE 20071238A1 PE 2007000019 A PE2007000019 A PE 2007000019A PE 2007000019 A PE2007000019 A PE 2007000019A PE 20071238 A1 PE20071238 A1 PE 20071238A1
Authority
PE
Peru
Prior art keywords
preparation
independently
heterocicles
aryl
useful
Prior art date
Application number
PE2007000019A
Other languages
English (en)
Inventor
Andrew J Staab
Ny Sin
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20071238A1 publication Critical patent/PE20071238A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)

Abstract

SE REFIERE A UN PROCESO PARA PREPARAR UN COMPUESTO DE FORMULA (4) EN DONDE X1, X2, X3 Y X4 SON INDEPENDIENTEMENTE N O CR2; SIEMPRE QUE SI X1 Y X2 SON N ENTONCES X3 ES CR2; Y SI X3 Y X4 SON N ENTONCES X2 ES CR2; R1 ES H Y -NRaRb; CADA R2 ES INDEPENDIENTEMENTE ALQUENILO, ALCOXI, ALQUILO, ARILO, ENTRE OTROS; Ra Y Rb SON INDEPENDIENTEMENTE H, ALQUENILO ALQUINILO, ARILO ENTRE OTROS; QUE COMPRENDE EN a) HACER REACCIONAR UN COMPUESTO DE FORMULA (3) CON UNA BASE SELECCIONADA DE TERC-BUTOXIDO DE POTASIO, DIISOPRILAMIDA DE LITIO, ENTRE OTRAS; FORMANDOSE UNA PRIMERA MEZCLA LLEVADA A CABO EN UN SOLVENTE ORGANICO; b) AJUSTAR EL pH DE LA PRIMERA MEZCLA A APROXIMADAMENTE 7 CON ACIDO CLORHIDICO O CLORURO DE AMONIO, EN UNA TEMPERATURA DE 20 A 40ºC; Y c) OPCIONALMENTE CALENTAR LA SEGUNDA MEZCLA DE REACCION ENTRE UNA TEMPERATURA DE 50 A 70ºC. ESTE PROCESO ES UTIL PARA LA PREPARACION DE COMPUESTOS INTERMEDIOS TAL COMO 6-METOXIISOQUINOLIN-1-OL, EL CUAL ES UTILIZADO EN LA PREPARACION DE DERIVADOS DE FENILGLICINAMIDA QUE SON UTILES EN EL TRATAMIENTO DE LA ENFERMEDAD TROMBOTICA
PE2007000019A 2006-01-09 2007-01-09 Proceso para la preparacion de heterociclos hidroxi substituidos PE20071238A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75725706P 2006-01-09 2006-01-09

Publications (1)

Publication Number Publication Date
PE20071238A1 true PE20071238A1 (es) 2008-01-14

Family

ID=37898590

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000019A PE20071238A1 (es) 2006-01-09 2007-01-09 Proceso para la preparacion de heterociclos hidroxi substituidos

Country Status (5)

Country Link
US (1) US20070161670A1 (es)
AR (1) AR058958A1 (es)
PE (1) PE20071238A1 (es)
TW (1) TW200736256A (es)
WO (1) WO2007082131A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
US7935670B2 (en) 2006-07-11 2011-05-03 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8343477B2 (en) 2006-11-01 2013-01-01 Bristol-Myers Squibb Company Inhibitors of hepatitis C virus
US7772180B2 (en) 2006-11-09 2010-08-10 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7763584B2 (en) 2006-11-16 2010-07-27 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7888464B2 (en) 2006-11-16 2011-02-15 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8003604B2 (en) 2006-11-16 2011-08-23 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8071766B2 (en) 2008-02-01 2011-12-06 Takeda Pharmaceutical Company Limited HSP90 inhibitors
US7964560B2 (en) 2008-05-29 2011-06-21 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8207341B2 (en) 2008-09-04 2012-06-26 Bristol-Myers Squibb Company Process or synthesizing substituted isoquinolines
US8957203B2 (en) 2011-05-05 2015-02-17 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8691757B2 (en) 2011-06-15 2014-04-08 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
CN103974955B (zh) 2011-08-23 2018-06-19 阿萨纳生物科技有限责任公司 嘧啶并-哒嗪酮化合物及其用途
AU2012392557B2 (en) 2012-10-19 2017-06-01 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
EP2914613B1 (en) 2012-11-02 2017-11-22 Bristol-Myers Squibb Company Hepatitis c virus inhibitors
US9643999B2 (en) 2012-11-02 2017-05-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9334279B2 (en) 2012-11-02 2016-05-10 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
WO2014070974A1 (en) 2012-11-05 2014-05-08 Bristol-Myers Squibb Company Hepatitis c virus inhibitors
CN105164148A (zh) 2013-03-07 2015-12-16 百时美施贵宝公司 丙型肝炎病毒抑制剂
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
WO2022006457A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
US11958861B2 (en) 2021-02-25 2024-04-16 Incyte Corporation Spirocyclic lactams as JAK2 V617F inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216571D0 (en) * 2002-07-17 2002-08-28 Celltech R&D Ltd Chemical compounds
US7309708B2 (en) * 2003-11-20 2007-12-18 Birstol-Myers Squibb Company Hepatitis C virus inhibitors
EP1856096B1 (en) * 2005-01-10 2010-09-01 Bristol-Myers Squibb Company Phenylglycinamide derivatives useful as anticoagulants

Also Published As

Publication number Publication date
US20070161670A1 (en) 2007-07-12
WO2007082131A1 (en) 2007-07-19
TW200736256A (en) 2007-10-01
AR058958A1 (es) 2008-03-05

Similar Documents

Publication Publication Date Title
PE20071238A1 (es) Proceso para la preparacion de heterociclos hidroxi substituidos
CY1124357T1 (el) Προσδιορισμος ανισορροπιας αλληλουχιας νουκλεϊκων οξεων
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
PE20070051A1 (es) Serin-amidas sustituidas con heteroaroilo
AR098260A2 (es) Polimorfo cristalino de una sal de bisulfato de un antagonista del receptor de trombina, proceso para su preparación, composición y forma purificada
AR061924A1 (es) Proceso para elaborar 2- amino -5 - halobenzamidas 3- sustituidas
AR073003A1 (es) Proceso para preparar 5-azacitosina nucleosidos y sus derivados
PE20061422A1 (es) Tigeciclina y metodos para preparar 9-nitrominociclina
ATE554065T1 (de) Sulfoniumsalz-fotoinitiatoren
EA200801607A1 (ru) Производные бензимидазолонкарбоновой кислоты
PE20081164A1 (es) Nuevos compuestos 521
CN107935940A (zh) 含能化合物2,4,6‑三氨基‑5‑硝基嘧啶‑1,3‑二氧化物的制备方法
AR079575A1 (es) Procedimiento para la purificacion de pirazoles
RU2012142172A (ru) Азотсодержащее гетероциклическое соединение и способ его получения
AR040968A1 (es) Bifenilcarboxamidas sustituidas con n- aril piperidina, un metodo para su preparacion, composicion farmaceutica y proceso de preparacion
PE20081693A1 (es) Derivados de cinolin-3-carboxamida como inhibidores de csf-1r
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
AR058210A1 (es) Procedimiento para preparar 5-amino-3h-tiazolo[4,5-d]pirimidin-2-ona, un intermediario util para la preparacion de ciertos nucleosidos de tiazolo[4,5-d]pirimidina que actuan como inmunomoduladores.
ES2532903T3 (es) Métodos y compuestos para la preparación de compuestos orgánicos biológicamente activos monofluorometilados
CN107108649B (zh) 用于制备噻吩并嘧啶化合物的新型方法及其中使用的中间体
BR112019017556A2 (pt) processo para a preparação de compostos de 2-cianoimidazol
BRPI0808570B8 (pt) processo para a preparação de inibidores de glyt-1
AR077332A1 (es) Procesos para la alquilacion de pirazoles
PE20090969A1 (es) Proceso para sintetizar compuestos de acido fosfonico y fosfinico
IL189527A0 (en) Chemical process

Legal Events

Date Code Title Description
FD Application declared void or lapsed